If it ain't broke don't fix it? Ethics of splinting deformed newborn ears.


Journal

Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 28 12 2017
revised: 13 01 2019
accepted: 24 03 2019
pubmed: 18 5 2019
medline: 15 4 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

Neonatal ear splinting is a proven and safe method to mold deformed ears into a more common shape. Based on our earlier studies, splinting is recommended only before the age of six weeks and preferably within the first week after birth. This can be done by initiating a system in which this intervention is actively proposed to parents. In this paper, we ethically evaluate such a system. By molding perfectly healthy newborn ears, we reach the boundary between treatment and enhancement. A key question is, therefore, whether we could classify neonatal ear splinting as a therapy. On the level of the individual, the advantages outweigh the drawbacks, but on the level of society, it is more complicated. Making ear deformities a part of official national screening programs fails to meet WHO criteria. Moreover, by systematically offering ear molding, professionals may be promoting guilt or fear of missing the opportunity. Additionally, it could affect societal attitudes toward cosmetic deformities. However, if we argue that on the individual level infants may benefit from ear splinting, then active detection of ear deformities allows parents to choose in a timely way from the full range of options, including splinting and a wait-and-see approach. We are inclined to optimally inform parents without setting up a full-blown public health program. The extent to which it is possible to timely offer splints to parents of newborns depends on the infrastructure of health care systems. The key will be for everyone involved, public or commercial, to responsibly educate and facilitate.

Identifiants

pubmed: 31097358
pii: S1748-6815(19)30155-X
doi: 10.1016/j.bjps.2019.03.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1396-1402

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Auteurs

M P van Wijk (MP)

Department of Plastic Surgery, Isala Zwolle, the Netherlands. Electronic address: ma.van.wijk@isala.nl.

R H P Wouters (RHP)

Department of Medical Humanities, Julius Center, University Medical Center Utrecht, the Netherlands.

A L Bredenoord (AL)

Department of Medical Humanities, Julius Center, University Medical Center Utrecht, the Netherlands.

M Kon (M)

Department of Plastic Surgery, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.

C C Breugem (CC)

Emma Children's Hospital UMC Amsterdam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH